Clinical Trials Directory

Trials / Unknown

UnknownNCT03057171

A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

Helicobacter pylori (H.pylori) is a major human pathogenic bacterium in gastric mucosa which is linked to the development of gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue lymphoma and gastric cancer. However the regulatory mechanism of H.pylori-induced immune response is not clear. Long non-coding RNA (lncRNA) has recently emerged as key post-transcriptional regulators of gene expression, differentiation. The investigators had a preliminary results which THRIL (TNFα and hnRNPL related immunoregulatory lincRNA) and PACER(p50-associated COX-2 extragenic RNA) played a potential role in H.pylori induced inflammatory cascade. However, there wasn't a previous study about expression of THRIL, PACER in a human tissue. Therefore, the investigators aimed to evaluate the expression of THRIL, PACER in patients with gastrointestinal disease according to H.pylori infection.

Conditions

Timeline

Start date
2015-05-01
Primary completion
2020-04-01
Completion
2020-04-01
First posted
2017-02-17
Last updated
2019-03-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT03057171. Inclusion in this directory is not an endorsement.